Reported Tuberculosis in the United States, 2019

Return to Main Menu

Table 9. Tuberculosis Cases and Percentages, by Multidrug Resistance (MDR)1, Origin of Birth, and Previous History of TB: United States, 1993–2019

See Surveillance Slide #42

Table 9. Tuberculosis Cases and Percentages, by Multidrug Resistance (MDR), Origin of Birth, and Previous History of TB: United States, 1993–2018
Year All MDR2 Multidrug Resistant TB Cases
Total MDR3 U.S.-Born MDR3 Non-U.S.–Born3,4 MDR
Previous TB No previous TB Previous TB No previous TB Previous TB No previous TB
Eligible No. (%) Eligible No. (%) Eligible No. (%) Eligible No. (%) Eligible No. (%) Eligible No. (%)
1993 484 982 76 (7.7) 16,603 407 (2.5) 668 30 (4.5) 11,808 301 (2.5) 301 46 (15.3) 4,667 103 (2.2)
1994 431 1,033 74 (7.2) 16,418 353 (2.2) 693 35 (5.1) 11,010 238 (2.2) 336 38 (11.3) 5,291 110 (2.1)
1995 327 958 70 (7.3) 16,024 254 (1.6) 592 28 (4.7) 10,340 169 (1.6) 364 42 (11.5) 5,653 85 (1.5)
1996 250 862 43 (5.0) 15,360 207 (1.3) 559 21 (3.8) 9,637 104 (1.1) 303 22 (7.3) 5,676 102 (1.8)
1997 201 742 44 (5.9) 14,451 155 (1.1) 455 12 (2.6) 8,698 76 (0.9) 286 32 (11.2) 5,708 79 (1.4)
1998 155 749 23 (3.1) 13,420 132 (1.0) 485 6 (1.2) 7,695 55 (0.7) 262 17 (6.5) 5,692 76 (1.3)
1999 157 669 28 (4.2) 12,658 127 (1.0) 382 6 (1.6) 7,011 39 (0.6) 284 22 (7.7) 5,595 88 (1.6)
2000 146 632 26 (4.1) 11,829 120 (1.0) 360 2 (0.6) 6,141 40 (0.7) 272 24 (8.8) 5,659 80 (1.4)
2001 151 629 33 (5.2) 11,516 115 (1.0) 324 7 (2.2) 5,571 34 (0.6) 302 26 (8.6) 5,909 81 (1.4)
2002 158 570 26 (4.6) 10,823 132 (1.2) 303 3 (1.0) 5,060 35 (0.7) 265 23 (8.7) 5,722 97 (1.7)
2003 119 524 21 (4.0) 10,753 94 (0.9) 253 2 (0.8) 4,853 23 (0.5) 271 19 (7.0) 5,870 70 (1.2)
2004 128 538 27 (5.0) 10,483 100 (1.0) 274 4 (1.5) 4,683 26 (0.6) 264 23 (8.7) 5,790 74 (1.3)
2005 125 507 23 (4.5) 10,063 98 (1.0) 240 2 (0.8) 4,393 20 (0.5) 267 21 (7.9) 5,653 77 (1.4)
2006 124 493 20 (4.1) 9,909 103 (1.0) 203 1 (0.5) 4,126 19 (0.5) 289 19 (6.6) 5,767 84 (1.5)
2007 124 496 19 (3.8) 9,655 101 (1.0) 206 3 (1.5) 3,849 18 (0.5) 288 16 (5.6) 5,763 83 (1.4)
2008 107 429 19 (4.4) 9,308 88 (0.9) 170 3 (1.8) 3,646 21 (0.6) 259 16 (6.2) 5,656 67 (1.2)
2009 115 343 19 (5.5) 8,230 95 (1.2) 116 1 (0.9) 3,092 12 (0.4) 226 18 (8.0) 5,130 83 (1.6)
2010 106 360 17 (4.7) 7,790 87 (1.1) 131 3 (2.3) 2,926 14 (0.5) 229 14 (6.1) 4,858 73 (1.5)
2011 128 343 27 (7.9) 7,538 101 (1.3) 135 1 (0.7) 2,691 17 (0.6) 208 26 (12.5) 4,844 84 (1.7)
2012 89 356 12 (3.4) 7,077 77 (1.1) 127 0 (0.0) 2,516 13 (0.5) 229 12 (5.2) 4,561 64 (1.4)
2013 96 300 12 (4.0) 6,859 83 (1.2) 98 2 (2.0) 2,280 7 (0.3) 202 10 (5.0) 4,574 76 (1.7)
2014 94 336 24 (7.1) 6,741 70 (1.0) 94 0 (0.0) 2,180 10 (0.5) 242 24 (9.9) 4,557 60 (1.3)
2015 88 317 16 (5.0) 6,957 72 (1.0) 100 3 (3.0) 2,189 10 (0.5) 217 13 (6.0) 4,763 62 (1.3)
2016 97 302 18 (6.0) 6,724 78 (1.2) 83 0 (0.0) 2,052 8 (0.4) 219 18 (8.2) 4,667 70 (1.5)
2017 129 280 26 (9.3) 6,577 102 (1.6) 59 2 (3.4) 1,841 17 (0.9) 221 24 (10.9) 4,732 85 (1.8)
2018 103 289 17 (5.9) 6,542 85 (1.3) 57 1 (1.8) 1,868 12 (0.6) 232 16 (6.9) 4,672 73 (1.6)
2019 90 276 15 (5.4) 6,270 74 (1.2) 62 1 (1.6) 1,730 11 (0.6) 214 14 (6.5) 4,532 63 (1.4)

Show More

1Resistance to at least isoniazid and rifampin. Isolates may be resistant to other drugs. Excludes cases with susceptibility testing not done or unknown for isoniazid and rifampin. Cases have been susceptibility tested to at least isoniazid and rifampin.
2This column provides an overall total of all MDR cases, including those whose previous history of TB is unknown and origin of birth is unknown.
3Excludes cases where previous history of TB is unknown and cases where origin of birth is unknown.
4Includes persons born outside the United States (including the U.S. territories), except persons born to at least one U.S. citizen parent.

Note: Data for all years updated through June 10, 2020. In 2019, one non-U.S.–born case had missing information on previous TB status and were excluded from the non-U.S.–born columns.